Evidence map›Paper›PMID 40369018›Full record

ArticleScientific reports2025

Syarul Nugroho, Hernawan Yuli Rahmadi, Arfan Nazhri Simamora, Abdul Razak Purba

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Syarul NugrohoPlant Breeding Research Group, Indonesian Oil Palm Research Institute, Jl. Brigjend Katamso No. 51, Medan, 20158, North Sumatera, Indonesia. synugroho@outlook.com.
Hernawan Yuli RahmadiPlant Breeding Research Group, Indonesian Oil Palm Research Institute, Jl. Brigjend Katamso No. 51, Medan, 20158, North Sumatera, Indonesia.
Arfan Nazhri SimamoraPlant Breeding Research Group, Indonesian Oil Palm Research Institute, Jl. Brigjend Katamso No. 51, Medan, 20158, North Sumatera, Indonesia.
Abdul Razak PurbaPlant Breeding Research Group, Indonesian Oil Palm Research Institute, Jl. Brigjend Katamso No. 51, Medan, 20158, North Sumatera, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oil palm plantations face serious challenges from Ganoderma boninense, a pathogen that causes basal stem rot (BSR), leading to significant productivity losses, with an estimated economic impact of 68.73%. Ganoderma spreads through direct root contact and airborne spores, affecting plantations across Indonesia, Malaysia, and other countries. Understanding the mechanisms of oil palm resistance to Ganoderma is crucial for developing effective strategies. Metabolomic profiling, ¹H NMR spectroscopy, offers a promising tool for identifying and quantifying metabolic changes associated with Ganoderma resistance. This study, ¹H NMR was employed to analyze root tissues of resistant, susceptible, and control oil palm seedlings exposed to Ganoderma. The results indicated that PCA effectively differentiated resistant palms from susceptible ones, while PLS-DA identified 14 significant metabolites. Further analysis using OPLS-DA and ROC revealed that ascorbic acid, D-gluconic acid, D-fructose, and 2-oxoisovalerate could serve as potential biomarkers for screening resistant palms. The metabolites identified in this study hold considerable promise for supporting breeding programs to develop oil palm varieties with enhanced resistance to BSR.

Indexed as

ArecaceaeDisease ResistanceGanodermaMetabolomeMetabolomicsPlant DiseasesPlant RootsProton Magnetic Resonance Spectroscopy1H NMRMetabolic biomarkersMetabolomic profilingOil palm resistance

Identifiers

PMID40369018
PMCPMC12078656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.